Delivery Order SPE2DB22D1202-SPE2DB24FUZX0

Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $4.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $14,303.90 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564309694 LUPRON DEPOT 11.25 MG 3MO KITS. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
The U.S. Defense Logistics Agency (DLA) awarded a $5,224.96 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LUPRON DEPOT 45 MG 6MO KITS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LUPRON DEPOT 11.25 MG 3MO KITS, a pharmaceutical product, with a potential value of $2,111.16. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order was issued under an Indefinite Delivery Contract (IDC) the company holds with DLA, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LUPRON DEPOT 3.75 MG KITS. The award has a completion date of January 29, 2024 and a potential value of $1,424.48. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp., the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $14,918.85 firm-fixed-price order is for the supply of 4,564,885,604 units of the drug Lupron Depot 3.75 mg kits. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of LUPRON DEPOT 3.75 MG KITS. This firm-fixed-price contract has a ceiling value of $4,551.83 and a completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,866,237 units of the pharmaceutical product LUPRON DEPOT 22.5 MG 3MO KITS. The $5,048.04 firm-fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, an agency within the U.S. Department of Defense. Amerisourcebergen, one of the largest pharmaceutical distribution companies, holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $44,876.70, is a delivery order contract for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty medication. The contract has an ultimate completion date of March 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is a delivery order with a firm fixed price of $17,489.40 and a completion date of December 23, 2024, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty pharmaceutical product. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This is a $4,435.13 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, a specialty medication product. The contract has an ultimate completion date of September 30, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FUZX0
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $4,926.04 to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, with a performance period ending on May 10, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 8/8/24, 10:37 AM